FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

391633002: Alemtuzumab 30mg/3mL infusion concentrate (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1465813010 Alemtuzumab 30mg/3mL infusion concentrate (product) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
    1485633019 Alemtuzumab 30mg/3mL infusion concentrate en Synonym Active Only initial character case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Alemtuzumab 30mg/3mL infusion concentrate Is a Product containing alemtuzumab false Inferred relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Has active ingredient Alemtuzumab false Inferred relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Has active ingredient Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Has active ingredient Biological agent false Inferred relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Has active ingredient Monoclonal antibody false Inferred relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Availability Available only as a proprietary false Additional relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate CSM recommendation to report adverse reactions Report all adverse reactions to the CSM false Additional relationship Existential restriction modifier
    Alemtuzumab 30mg/3mL infusion concentrate Product name type Generic name false Additional relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start